Cutaneous metastasis of renal cell carcinoma: Fine needle aspiration provides rapid diagnosis
The diagnosis of cutaneous metastasis of renal cell carcinoma is challenging in a young person in absence of a prior history of cancer. In such situation, fine needle aspiration alone as a minimally invasive procedure can provide rapid, accurate and cost effective diagnosis, even in case of unknown primary.01/23/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 23, 2019 Category: Urology & Nephrology Source Type: news

Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
In the ongoing phase 3, CheckMate 214 trial, nivolumab plus ipilimumab improved overall survival compared with sunitinib in patients with intermediate or poor risk, previously untreated, advanced renal cell carcinoma.01/23/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 23, 2019 Category: Urology & Nephrology Source Type: news

Ten-Year Outcomes of Renal Tumor Radio Frequency Ablation
According to a study that was published by the Journal of Urology, a total of 112 tumors in 106 patients were treated with radio frequency ablation. The median followup was 79 months (IQR 28.9-121.1) and mean ± SD tumor size was 2.5 ± 0.8 cm. Initial technical success was achieved in 97 percent of cases.01/23/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 23, 2019 Category: Urology & Nephrology Source Type: news

Personalized treatment benefits kidney cancer patients
Personalized treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk factors for worsening kidney disease, according to a new study published in the journal Radiology.01/16/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 16, 2019 Category: Urology & Nephrology Source Type: news

Immunotherapy/VEGF Inhibitor Combos to Define Frontline Standard in mRCC
VEGF TKIs have long defined the frontline standard of care in metastatic renal cell carcinoma (mRCC), but several promising trials evaluating their use in combination with immunotherapy agents may redefine the frontline setting in this patient population.01/15/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 15, 2019 Category: Urology & Nephrology Source Type: news

European Commission Approves Opdivo (nivolumab) Plus Low-Dose Yervoy (ipilimumab) for First-Line Treatment of Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma
Yesterday, Bristol-Myers Squibb announced that the European Commission has approved the combination of Opdivo (nivolumab) 3 mg/kg plus Yervoy (ipilimumab) 1 mg/kg ( “low-dose”) for the first-line treatment of patients with intermediate- and poor-risk advanced renal cell carcinoma (RCC).01/15/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 15, 2019 Category: Urology & Nephrology Source Type: news

Royal Jelly May Ease Adverse Effects of RCC Drug Therapy
Royal jelly, a substance secreted by worker honeybees that is the exclusive food for queen bees, may ease the adverse effects of tyrosine kinase inhibitor (TKI) therapy for advanced renal cell carcinoma (RCC).01/11/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 11, 2019 Category: Urology & Nephrology Source Type: news

New breath test for cancer currently under trial
A clinical trial in the U.K. has just launched to assess the effectiveness of a newly developed breath test that could help diagnose multiple forms of cancer, including kidney cancer.01/09/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 9, 2019 Category: Urology & Nephrology Source Type: news

US cancer death rate hits 25 years of decline, study says
The rate of people dying from cancer in the United States seems to have dropped steadily for 25 years, a new study says, but disparities remain between the rich and the poor. The overall nationwide cancer death rate fell continuously from 1991 to 2016 by a total of 27%, according to a study by the American Cancer Society, published Tuesday in CA: A Cancer Journal for Clinicians.01/08/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 8, 2019 Category: Urology & Nephrology Source Type: news

Clinical Trials to Treat Kidney (Renal Cell) Cancer
Looking to enroll in a clinical trial? Check out this list from the National Cancer Institute.01/08/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 8, 2019 Category: Urology & Nephrology Source Type: news

Biological Cartographers Seek To Map The Trillions Of Cells In The Human Body
There's an effort underway to make a new atlas of all the cells in the human body and to describe each cell type using all the powerful tools of today's genetic technology. The study will take quite a few years to complete but scientists say the payoff will be huge. Through this study, they are hoping to gain new insights into many different diseases such as cancer.01/07/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 7, 2019 Category: Urology & Nephrology Source Type: news

Stereotactic Radiosurgery for Multiple Brain Metastases From Renal-Cell Carcinoma
This study discusses stereotactic radiosurgery for multiple brain metastases from renal-cell carcinoma.01/04/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 4, 2019 Category: Urology & Nephrology Source Type: news

Some RCC Risk Factors Can Be Modified
Obesity, hypertension and smoking are the three modifiable risk factors that could aggressively be targeted to reduce renal cell carcinoma, according to a new study that was done by the University of Texas Health Science Center and the South Texas Veterans Healthcare System.01/03/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 3, 2019 Category: Urology & Nephrology Source Type: news

A healthy organic diet reduces the risk of cancer by 65 percent
A recent study found that a healthy diet can reduce the risk of cancer by up to 65 percent.01/02/2019 (Source: Kidney Cancer Association)
Source: Kidney Cancer Association - January 2, 2019 Category: Urology & Nephrology Source Type: news